Parvalbumin Cell Ablation of NMDA-R1 Leads to Altered Phase, But Not Amplitude, of Gamma-Band Cross-Frequency Coupling.

Registration Now Open for

ADOS-2 Clinical Training Workshop

November 25-27. Click here for info!

TitleParvalbumin Cell Ablation of NMDA-R1 Leads to Altered Phase, But Not Amplitude, of Gamma-Band Cross-Frequency Coupling.
Publication TypeJournal Article
Year of Publication2019
AuthorsPort, RG, Berman, JI, Liu, S, Featherstone, RE, Roberts, TPL, Siegel, SJ
JournalBrain Connect
Date Published2019 04

Altered gamma-band electrophysiological activity in individuals with autism spectrum disorder (ASD) is well documented, and analogous gamma-band alterations are recapitulated in several preclinical murine models relevant to ASD. Such gamma-band activity is hypothesized to underlie local circuit processes. Gamma-band cross-frequency coupling (CFC), a related though distinct metric, interrogates local neural circuit signal integration. Several recent studies have observed perturbed gamma-band CFC in individuals with ASD, although the direction of change remains unresolved. It also remains unclear whether murine models relevant to ASD recapitulate this altered gamma-band CFC. As such, this study examined whether mice with parvalbumin (PV) cell-specific ablation of NMDA-R1 (PV/NR1) demonstrated altered gamma-band CFC as compared with their control littermates (PV/NR1-mice that do not have the PV cell-specific ablation of NMDA-R1). Ten mice of each genotype had 4 min of "resting" electroencephalography recorded and analyzed. First, resting electrophysiological power was parsed into the canonical frequency bands and genotype-related differences were subsequently explored so as to provide context for the subsequent CFC analyses. PV/NR1 mice exhibited an increase in resting power specific to the high gamma-band, but not other frequency bands, as compared with PV/NR1. CFC analyses then examined both the standard magnitude (strength) of CFC and the novel metric Phase-which denotes the phase of the lower frequency signal at which the peak higher frequency signal power occurred. PV/NR1 mice exhibited altered Phase, but not strength, of gamma-band CFC as compared with PV/NR1 mice. As such, this study suggests a potential novel metric to explore when studying neuropsychiatric disorders.

Alternate JournalBrain Connect
PubMed ID30588822
PubMed Central IDPMC6479236
Grant ListP50 MH096891 / MH / NIMH NIH HHS / United States
T32 MH019112 / MH / NIMH NIH HHS / United States
R01 DC008871 / DC / NIDCD NIH HHS / United States
R21 MH110869 / MH / NIMH NIH HHS / United States
K01 MH096091 / MH / NIMH NIH HHS / United States
U54 HD086984 / HD / NICHD NIH HHS / United States